Asthma isn't a risk factor for worsening COVID-19: study
(HealthDay)—People with asthma can breathe a little easier: New research suggests the condition does not increase your risk of hospitalization due to COVID-19.
Jun 19, 2020
0
16
(HealthDay)—People with asthma can breathe a little easier: New research suggests the condition does not increase your risk of hospitalization due to COVID-19.
Jun 19, 2020
0
16
(HealthDay)—For adults with exacerbation of chronic obstructive pulmonary disease (COPD), antibiotics and systemic corticosteroids are associated with less treatment failure, according to a review published online Feb. ...
Feb 25, 2020
0
2
(HealthDay)—There is dramatic seasonal variation in rates of admissions for chronic obstructive pulmonary disease (COPD) exacerbation, according to a study presented at CHEST 2019, the annual meeting of the American College ...
Oct 25, 2019
0
3
New research from scientists at the University of Alabama at Birmingham published in the New England Journal of Medicine has found that beta-blockers used in a clinical trial for patients with chronic obstructive pulmonary ...
Oct 22, 2019
0
15
Chronic obstructive pulmonary disease, or COPD, is the third leading cause of death in the U.S., according to the American Lung Association. More than 15.3 million people in this country suffer from it and they often experience ...
Sep 30, 2019
0
7
More than 15.3 million people in the U.S. suffer from chronic obstructive pulmonary disease (COPD), which is the third leading cause of death in this country, according to the American Lung Association. Patients often experience ...
May 20, 2019
0
0
The antibiotic azithromycin may reduce treatment failure in patients hospitalized for an acute exacerbation of chronic obstructive pulmonary disease (COPD), according to a randomized, controlled trial published online in ...
May 3, 2019
0
2
New research published in the American Journal of Respiratory and Critical Care Medicine from the University of Alabama at Birmingham shows that video telehealth pulmonary rehabilitation interventions reduce 30-day all-cause ...
Apr 26, 2019
0
2
(HealthDay)—A de-escalation from triple therapy to indacaterol/glycopyrronium may lead to a small reduction in lung function in non-frequently exacerbating patients with chronic obstructive pulmonary disease (COPD) but ...
Sep 15, 2018
0
1
(HealthDay)—For children with cystic fibrosis (CF) and early Pseudomonas aeruginosa (Pa) infection, the risk of pulmonary exacerbation is significantly reduced with the addition of azithromycin to tobramycin inhalation ...
Jun 28, 2018
0
0